ViroPharma (VPHM)

SUMMARY

BULLS

BEARS

DATA CENTRAL

Day
52 Wk

These 5 Stocks Have a Little Magic

Motley Fool Jun 23

Can a simple formula increase your portfolio's returns?

The FDA Requests Additional Clinical Study Regarding ViroPharma's (VPHM) Drug

StreetInsider.com Jun 4

Visit StreetInsider.com at http://www.streetinsider.com/FDA/The+FDA+Requests+Additional+Clinical+Study+Regarding+ViroPharma%27s+%28VPHM%29+Drug/4707642.html for the full story.

The Clouds Are Parting

Motley Fool May 29

ViroPharma gets its day in FDA court.

Will the FDA Approve These Drugs?

Motley Fool May 26

Plenty of PDUFA dates are right around the corner.

Bernanke Spies the Bottom

Motley Fool May 13

Do we believe him?

This Just In: Upgrades and Downgrades

Motley Fool Apr 29

JMP sticks a fork in Intuitive Surgical and calls it done.

ViroPharma Incorporated Reports First Quarter 2009 Financial Results

PR News Wire Apr 29

- Company Achieves Record First Quarter of Net Product Sales; Quarter Highlighted by Nearly $7 Million in Net Sales of Cinryze(TM) C1 Esterase Inhibitor (Human) - EXTON, Pa., April 29 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM)

VPHM : Lev acquisition appraisal

Blogvesting Jul 29

Viropharma recently acquired Lev Pharmaceuticals for $443 million ($2.75 per Lev share), primarily for its orphan drug Cinryze, which is used to treat HAE (hereditary angioedema). There are additional payouts of $0.50 per share if Cinryze gets...

VPHM : Value in a pharmaceutical

Blogvesting Nov 11

Generally, I tend to stay away from pharmaceuticals, because I find it difficult to accurately handicap the odds of drug trials. However, I have decided to make an exception in this case, because Viropharma (VPHM) has been so severely beaten down...

Suggest other news sources for this topic


	Suggest a News Source Topic Top news source/blog that we're missing Why do you recommend this news source? Close Thanks for your suggestion!

The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.

[edit] References

Retrieved from "http://www.wikinvest.com/stock/ViroPharma_(VPHM)"

Categories: Pharma & Healthcare | Biotechnology

Worried about pump and dump?

We review changes
for stock spam

» read more

Want to make Wikinvest better?

We need your help,
contribute today

» learn how

Do you write software?

We are recruiting
the best engineers

» view jobs

Like Wikinvest?

Spread the word —
Tell your friends!

» spread the word

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.